Once doomed to a life of darkness, dozens of people stricken by retinal diseases are rediscovering a world of light, as scientists push ahead on cures for blindness.
Already, bionic retinas enable blind people to “see” sidewalks, doorways and even oversized text, while gene therapy has allowed a small boy to put away his white cane and take up Little League baseball.
Drugs are being used to halt some age-related forms of blindness, and in lab dishes, stem cells are being coaxed into forming retinal tissue in early proof-of-concept work.
Photo: AFP
“Things that were thought impossible a few years ago are a reality today,” Maria Canto-Soler, director of the Retinal Degeneration Research Center at Johns Hopkins University in the US told reporters. “It would not be appropriate to say that we will find ways to cure retinal degenerative diseases in just a few more years, but we are surely on the right track... It is just a matter of time.”
Retinal degenerative diseases like retinitis pigmentosa affect more than 30 million people around the world, according to the Foundation Fighting Blindness, based in Columbia, Maryland.
The tally includes age-related macular degeneration, which is the leading cause of blindness in people over 50 in developing countries, and Usher syndrome, which is the main cause of combined deafness and blindness.
Scientists hope that soon, diagnosis with a degenerative retinal disease will not amount to a sentence of life-long disability. No longer in the realm of science fiction, bionic retinas are already changing the lives of several dozen people who use them today in the US and Europe, where they are available for sale.
The system is built around a chip implanted in the eye to mimic the function of photoreceptor cells, typically combined with a miniature camera mounted in a pair of sporty-looking sunglasses.
The camera sends images via a minicomputer to the chip, which converts them to electrical signals to the brain, where they are interpreted as vision. In one patent, the chip itself also functions as photoreceptor and transmitter.
After a short re-education, implant recipients start making out shapes and light patterns, allowing them to avoid obstacles in their path and even read large signs.
“It has changed everything. I can stop at the curb edge now, cross the road and find the other curb on the other side,” says “Mr K,” who received the Argus II prosthesis manufactured by California-based Second Sight in 2009.
“If I go to the pub, I know where people are. I cannot make out the faces, but I know there are other people around instead of sitting in a darkened room, never knowing if you are talking to yourself or someone next to you. It is just uplifting; it is just great,” he said in a video testimonial.
Yet, the device remains off-limits for many, costing more than 100,000 euros (US$135,000).
Another promising field is gene therapy.
An ongoing clinical trial led by Children’s Hospital of Philadelphia has restored some vision to 40 children and young adults who were virtually blind from a severe form of retinitis pigmentosa.
One of them, Corey Haas, “put away his white cane and can now see the blackboard at school,” the foundation said.
Gene therapy works by injecting corrective genes into the cells of the retina to replace defective ones. A single treatment can last several years, possibly a lifetime.
Haas received the treatment in 2008, aged eight.
In a video from September last year, he is shown running around outdoors wearing a light pair of glasses, hitting nails into a wood block, riding a bike and building with Lego blocks.
“Four days after the surgery we were going into the zoo, and Corey goes: ‘The sun’s hurting my eyes’ — that’s never happened,” said his mother, Nancy.
Researchers are also investigating stem cells, immature cells that can be coaxed to become any type of cell in the human body.
Earlier this month, Canto-Soler and a team said that they had used stem cells to create human retinal tissue in the lab that “has the ability to sense light” — “a good start” toward the goal of genetically engineered cell transplants to cure blindness.
“Thanks to extraordinary advances in retinal research over the past decade, sight-saving and restoring treatments are becoming available and several more are moving into clinical trials,” Foundation Fighting Blindness chief research officer Stephen Rose told reporters.
“Innovations in gene therapies, stem cells and bionic retinas are moving us closer to eradicating the entire spectrum of devastating retinal diseases.”
SEEKING CHANGE: A hospital worker said she did not vote in previous elections, but ‘now I can see that maybe my vote can change the system and the country’ Voting closed yesterday across the Solomon Islands in the south Pacific nation’s first general election since the government switched diplomatic allegiance from Taiwan to Beijing and struck a secret security pact that has raised fears of the Chinese navy gaining a foothold in the region. The Solomon Islands’ closer relationship with China and a troubled domestic economy weighed on voters’ minds as they cast their ballots. As many as 420,000 registered voters had their say across 50 national seats. For the first time, the national vote also coincided with elections for eight of the 10 local governments. Esther Maeluma cast her vote in the
Nearly half of China’s major cities are suffering “moderate to severe” levels of subsidence, putting millions of people at risk of flooding, especially as sea levels rise, according to a study of nationwide satellite data released yesterday. The authors of the paper, published by the journal Science, found that 45 percent of China’s urban land was sinking faster than 3mm per year, with 16 percent at more than 10mm per year, driven not only by declining water tables, but also the sheer weight of the built environment. With China’s urban population already in excess of 900 million people, “even a small portion
UNSETTLING IMAGES: The scene took place in front of TV crews covering the Trump trial, with a CNN anchor calling it an ‘emotional and unbelievably disturbing moment’ A man who doused himself in an accelerant and set himself on fire outside the courthouse where former US president Donald Trump is on trial has died, police said yesterday. The New York City Police Department (NYPD) said the man was declared dead by staff at an area hospital. The man was in Collect Pond Park at about 1:30pm on Friday when he took out pamphlets espousing conspiracy theories, tossed them around, then doused himself in an accelerant and set himself on fire, officials and witnesses said. A large number of police officers were nearby when it happened. Some officers and bystanders rushed
HYPOCRISY? The Chinese Ministry of Foreign Affairs yesterday asked whether Biden was talking about China or the US when he used the word ‘xenophobic’ US President Joe Biden on Wednesday called for a hike in steel tariffs on China, accusing Beijing of cheating as he spoke at a campaign event in Pennsylvania. Biden accused China of xenophobia, too, in a speech to union members in Pittsburgh. “They’re not competing, they’re cheating. They’re cheating and we’ve seen the damage here in America,” Biden said. Chinese steel companies “don’t need to worry about making a profit because the Chinese government is subsidizing them so heavily,” he said. Biden said he had called for the US Trade Representative to triple the tariff rates for Chinese steel and aluminum if Beijing was